Investar Holding Corporation (ISTR)

CTI BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	55.22	27.92	32.01	40.26	97.04	35.37
Investment Securities	59.18	122.61	99.26	113.72	107.03	111.49
Trading Asset Securities	-	17.2	17.33	-	2.6	-
Mortgage-Backed Securities	355.71	274.1	301.13	329.81	277.33	185.95
Total Investments	414.89	413.9	417.71	443.53	386.97	297.44
Gross Loans	2,106	2,126	2,212	2,106	1,874	1,864
Allowance for Loan Losses	-26.62	-26.72	-30.54	-24.36	-20.86	-20.36
Other Adjustments to Gross Loans	-	-1	-1.1	-1.3	-1.8	-3.2
Net Loans	2,080	2,098	2,180	2,080	1,851	1,840
Property, Plant & Equipment	39.89	40.71	44.18	49.59	58.08	56.3
Goodwill	40.09	40.09	40.09	40.09	40.09	28.14
Other Intangible Assets	1.34	1.61	2.23	3.06	3.95	4.09
Loans Held for Sale	-	-	-	-	0.62	-
Accrued Interest Receivable	14.03	14.42	14.37	12.75	11.36	12.97
Long-Term Deferred Tax Assets	15.33	17.12	16.91	16.44	2.24	1.36
Other Real Estate Owned & Foreclosed	5.63	5.22	4.44	0.68	2.65	0.66
Other Long-Term Assets	81.91	63.47	63.14	67.02	59.06	44.89
Total Assets	2,748	2,723	2,815	2,754	2,513	2,321
Interest Bearing Deposits	1,890	1,722	1,629	1,346	1,239	1,066
Institutional Deposits	-	192.1	178.1	155.8	295.63	373.43
Non-Interest Bearing Deposits	448.46	432.14	448.75	580.74	585.47	448.23
Total Deposits	2,338	2,346	2,256	2,082	2,120	1,888
Short-Term Borrowings	11.02	25.57	238.46	333.5	5.78	7.87
Current Portion of Long-Term Debt	-	7.22	23.5	-	-	42
Current Portion of Leases	-	0.45	-	-	-	-
Current Income Taxes Payable	47.43	9.61	9.95	7.42	9.68	10.76
Long-Term Debt	16.72	16.7	44.32	44.23	42.99	42.9
Federal Home Loan Bank Debt, Long-Term	70	60	-	53.5	78.5	78.5
Long-Term Leases	-	1.65	2.2	2.9	-	-
Trust Preferred Securities	8.78	8.73	8.63	8.52	8.38	5.95
Other Long-Term Liabilities	-	5.64	5.6	5.6	5	2.1
Total Liabilities	2,492	2,482	2,588	2,538	2,271	2,078
Common Stock	9.84	9.83	9.75	9.9	10.34	10.61
Retained Earnings	141.61	132.94	116.71	108.21	76.16	71.39
Comprehensive Income & Other	104.48	98.53	100.31	97.67	156.1	161.29
Shareholders' Equity	255.93	241.3	226.77	215.78	242.6	243.28
Total Liabilities & Equity	2,748	2,723	2,815	2,754	2,513	2,321
Total Debt	106.52	120.32	317.11	442.64	135.66	177.22
Net Cash (Debt)	-51.3	-75.2	-267.77	-402.38	-36.02	-141.85
Net Cash Per Share	-5.14	-7.57	-27.21	-39.52	-3.43	-13.05
Filing Date Shares Outstanding	9.84	9.83	9.78	9.91	10.31	10.48
Total Common Shares Outstanding	9.84	9.83	9.75	9.9	10.34	10.61
Book Value Per Share	26.01	24.55	23.26	21.79	23.45	22.93
Tangible Book Value	214.5	199.6	184.45	172.64	198.56	211.05
Tangible Book Value Per Share	21.80	20.31	18.92	17.43	19.20	19.89

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.

SEC Filings: 10-K · 10-Q